Stanford T. Shulman

发表

Feasibility of exercise stress echocardiography for the follow-up of children with coronary involvement secondary to Kawasaki disease.

S. Shulman, F. Chaudhry, W. Neches, 1995, Circulation.

Prevention of infective endocarditis: guidelines from the American Heart Association: a guideline from the American Heart Association Rheumatic Fever, Endocarditis and Kawasaki Disease Committee, Council on Cardiovascular Disease in the Young, and the Council on Clinical Cardiology, Council on Cardi

D. Goff, R. Bonow, A. Bolger, 2007, Journal of the American Dental Association.

Prevention of Infective Endocarditis

J. Newburger, L. Baddour, S. Shulman, 2007, Pediatrics.

Guidelines for long-term management of patients with Kawasaki disease. Report from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association.

M. Freed, S. Shulman, K. Taubert, 1994, Circulation.

Prevention of Rheumatic Fever

H. Millard, Alan L. Bisno, Chatrchai Watanakunakorn, 1956 .

Cardiac transplantation for Kawasaki disease.

S. Shulman, R. Shaddy, E. Pahl, 1997, Pediatrics.

Circulating Cardiac Troponin I Levels in Kawasaki Disease

S. Shulman, J. Borensztajn, P. Checchia, 2001, Pediatric Cardiology.

Single-dose ceftriaxone pharmacokinetics in pediatric patients with central nervous system infections.

S. Shulman, R. Yogev, I. Patel, 1983, The Journal of pediatrics.

A Statement for Health Professionals From the Committee on Rheumatic Fever, Endocarditis and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association Endorsed by the American Academy of Pediatrics

Walter R Wilson, Larry M Baddour, Jane C Burns, 2004 .

Prevention of bacterial endocarditis. Recommendations by the American Heart Association.

A. Bolger, J. Newburger, S. Shulman, 1997, JAMA.

Prevention of bacterial endocarditis.

A. Bisno, D. Durack, S. Shulman, 1991, Connecticut medicine.

Generalized nonsuppurative myositis with staphylococcal septicemia.

S. Shulman, W. Ballinger, E. Garin, 1980, The Journal of pediatrics.

Immunoconglutinin and Complement Studies in Congenital Nephrotic Syndrome and Nephritis of Henoch-Schönlein Purpura in Children

T. Barratt, S. Shulman, J. Soothill, 1971, Archives of disease in childhood.

A double-blind evaluation of transfer factor therapy of HBsAg-positive chronic aggressive hepatitis: preliminary report of efficacy.

S. Shulman, E. Ayoub, J. Mcguigan, 1979, Cellular immunology.

CD84 is markedly up‐regulated in Kawasaki disease arteriopathy

J. Orenstein, M. Lingen, S. Baker, 2014, Clinical and experimental immunology.

Enzyme replacement therapy and monitoring for children with type 1 Gaucher disease: consensus recommendations.

Arslanian, P. Kaplan, J. Charrow, 2004, The Journal of pediatrics.

Is there an association between Kawasaki disease and Chlamydia pneumoniae?

S. Shulman, M. Hammerschlag, S. Strigl, 2000, The Journal of infectious diseases.

Large outbreak of pertussis among young children in Chicago, 1993: investigation of potential contributing factors and estimation of vaccine effectiveness.

T. Kenyon, S. Shulman, P. Strebel, 1996, The Pediatric infectious disease journal.

Kawasaki Disease and Exposure to Fine Particulate Air Pollution.

C. Pope, B. McCrindle, J. Newburger, 2016, The Journal of pediatrics.